Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Galanti | Beauty & Personal Care | 28.3% | 91st pct | 35 |
| Beauty Life | Beauty & Personal Care | 20.5% | 74th pct | 35 |
| Estel Georgia | Beauty & Personal Care | 4.9% | 23rd pct | 35 |
| Medea International | Beauty & Personal Care | — | no FY data | 35 |
| Paberliki - Sakartvelo | Beauty & Personal Care | — | no FY data | 35 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 3 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Ratio — FY 2024 | Beauty Life | Estel Georgia | Galanti | Medea International | Paberliki - Sakartvelo |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 58.9% | 23.5% | 31.1% | — | — |
| EBITDA Margin | 20.5% | 4.9% | 28.3% | — | — |
| EBITDAR | 2,493 | 871 | 1,999 | — | — |
| EBITDAR Margin | 20.5% | 7.7% | 28.3% | — | — |
| EBIT Margin | 14.5% | 3.8% | 28.3% | — | — |
| Net Profit Margin | 13.5% | 43.9% | 22.1% | — | — |
| Operating Expense % of Sales | 38.4% | 18.6% | 2.7% | — | — |
| Returns | |||||
| Return on Assets (ROA) | 8.8% | 14.5% | 47.6% | — | — |
| Return on Equity (ROE) | 11.0% | 61.5% | 51.2% | — | — |
| ROIC [EBIT / Invested Capital] | 9.7% | 1.3% | 70.4% | — | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 19.8% | 76.4% | 0.0% | — | — |
| Debt-to-Equity | 0.25x | 3.25x | 0.00x | — | — |
| Debt-to-EBITDA | 1.49x | 47.39x | 0.00x | — | — |
| Equity-to-Assets | 79.3% | 23.5% | 92.9% | — | — |
| Net Debt | 3,206 | 25,658 | -207 | — | — |
| Cash & Equivalents | 508 | 581 | 207 | — | — |
| Total Debt | 3,714 | 26,240 | N/A | — | — |
| Liquidity & working capital | |||||
| Current Ratio | 352.62x | 458.28x | 4.73x | — | — |
| Quick Ratio | 352.62x | 458.28x | 4.73x | — | — |
| Cash Ratio | 25.87x | 15.34x | 0.89x | — | — |
| Total Current Assets | 6,929 | 17,366 | 1,103 | — | — |
| Total Current Liabilities | 20 | 38 | 233 | — | — |
| Inventory | N/A | N/A | N/A | — | — |
| Trade Receivables | 2,263 | 1,586 | 878 | — | — |
| Trade Payables | N/A | N/A | 197 | — | — |
| Net Working Capital | 6,909 | 17,328 | 870 | — | — |
| Net Working Capital % of Revenue | 56.9% | 153.1% | 12.3% | — | — |
| Trade Working Capital | 2,263 | 1,586 | 681 | — | — |
| Trade Working Capital % of Revenue | 18.6% | 14.0% | 9.7% | — | — |
| Change in Trade Working Capital | N/A | N/A | N/A | — | — |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | N/A | N/A | — | — |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | — | — |
| Receivables Turnover | 5.37x | 7.13x | 8.03x | — | — |
| Days Sales Outstanding (DSO) | 68.0 | 51.2 | 45.4 | — | — |
| Payables Turnover | N/A | N/A | 24.68x | — | — |
| Days Payable Outstanding (DPO) | N/A | N/A | 14.8 | — | — |
| Cash Conversion Cycle | 68.0 days | 51.2 days | 30.7 days | — | — |
| Asset Turnover | 0.65x | 0.33x | 2.15x | — | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | N/A | -2,001 | 2,019 | — | — |
| Free Cash Flow (OCF − Capex proxy) | N/A | -10,757 | -366 | — | — |
| Cash Conversion (OCF / EBITDA) | N/A | -361.4% | 101.0% | — | — |
| Dividends Declared | N/A | N/A | N/A | — | — |
| Dividend Payout Ratio | N/A | N/A | N/A | — | — |